These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18622421)

  • 1. Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy.
    Costa LJ; Rodriguez V; Porrata LF; Lacy MQ; Elliott MA; Gertz MA; Gastineau DA; Litzow MR
    Bone Marrow Transplant; 2008 Oct; 42(7):497-8. PubMed ID: 18622421
    [No Abstract]   [Full Text] [Related]  

  • 2. Translocation (X;10) in a child with therapy-related acute myeloid leukemia following chemotherapy for Ewing's Sarcoma.
    Abla O; Dror Y; Shago M
    Cancer Genet Cytogenet; 2007 Oct; 178(2):168-9. PubMed ID: 17954276
    [No Abstract]   [Full Text] [Related]  

  • 3. Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation.
    Waterman J; Rybicki L; Bolwell B; Copelan E; Pohlman B; Sweetenham J; Dean R; Sobecks R; Andresen S; Kalaycio M
    Bone Marrow Transplant; 2012 Apr; 47(4):488-93. PubMed ID: 21572461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.
    Carney DA; Westerman DA; Tam CS; Milner A; Prince HM; Kenealy M; Wolf M; Januszewicz EH; Ritchie D; Came N; Seymour JF
    Leukemia; 2010 Dec; 24(12):2056-62. PubMed ID: 20962860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis.
    Forrest DL; Nevill TJ; Naiman SC; Le A; Brockington DA; Barnett MJ; Lavoie JC; Nantel SH; Song KW; Shepherd JD; Sutherland HJ; Toze CL; Davis JH; Hogge DE
    Bone Marrow Transplant; 2003 Nov; 32(9):915-23. PubMed ID: 14561993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.
    Au WY; Chan LC; Liang R; Kwong YL
    Am J Hematol; 2006 Jun; 81(6):471-3. PubMed ID: 16680740
    [No Abstract]   [Full Text] [Related]  

  • 7. Myeloablative therapy, stem cell rescue and gene transfer in advanced Ewing tumors.
    Burdach S; Nürnberger W; Laws HJ; Engel BC; Dirksen U; Krauth K; Pape H; Kahn T; Körholz D; Gadner H; Göbel U; Jürgens H
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S67-8. PubMed ID: 8899179
    [No Abstract]   [Full Text] [Related]  

  • 8. Special clinical concerns/problems in the management of MDS and secondary acute myeloid leukemias.
    Venugopal P; Manson S; Preisler HD
    Cancer Treat Res; 2001; 108():257-65. PubMed ID: 11702603
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes.
    Ballen KK; Antin JH
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):477-93. PubMed ID: 8468276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabine.
    Arana-Yi C; Block AW; Sait SN; Ford LA; Barcos M; Baer MR
    Leuk Res; 2008 Jul; 32(7):1043-8. PubMed ID: 18093651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?
    Hake CR; Graubert TA; Fenske TS
    Bone Marrow Transplant; 2007 Jan; 39(2):59-70. PubMed ID: 17143301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies.
    Kollmannsberger C; Hartmann JT; Kanz L; Bokemeyer C
    J Cancer Res Clin Oncol; 1998; 124(3-4):207-14. PubMed ID: 9619748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.
    Friedberg JW
    Haematologica; 2008 Mar; 93(3):336-8. PubMed ID: 18310538
    [No Abstract]   [Full Text] [Related]  

  • 14. Secondary primary malignancies in patients with multiple myeloma treated with high-dose chemotherapy and autologous blood stem cell transplantation.
    Fenk R; Neubauer F; Bruns I; Schröder T; Germing U; Haas R; Kobbe G
    Br J Haematol; 2012 Mar; 156(5):683-6. PubMed ID: 22050384
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy for metastatic ESFT: is it time to ask new questions?
    Snyder KM; Mackall CL
    Pediatr Blood Cancer; 2007 Aug; 49(2):115-6. PubMed ID: 17474114
    [No Abstract]   [Full Text] [Related]  

  • 16. [Four cases of therapy-related leukemia in multiple myeloma].
    Natori K; Izumi H; Kaneko K; Ishihara S; Nagase D; Fujimoto Y; Kato M; Umeda M; Kuraishi Y
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):121-4. PubMed ID: 17220686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Philadelphia chromosome-positive acute lymphoblastic leukemia secondary to chemoradiotherapy for Ewing sarcoma. Report of two cases and concise review of the literature.
    Snyder DS; Stein AS; O'Donnell MR; Gaal K; Slovak ML; Forman SJ
    Am J Hematol; 2005 Jan; 78(1):74-8. PubMed ID: 15609284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyria cutanea tarda in a patient with post-transplant MDS.
    Oubre D; Cruz J; Keung Y
    Bone Marrow Transplant; 2001 Jan; 27(2):219-20. PubMed ID: 11281395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment.
    Coorens THH; Collord G; Lu W; Mitchell E; Ijaz J; Roberts T; Oliver TRW; Burke GAA; Gattens M; Dickens E; Nangalia J; Tischkowitz M; Anderson J; Shlien A; Godfrey AL; Murray MJ; Behjati S
    Blood; 2021 May; 137(21):2992-2997. PubMed ID: 33598691
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy-related myelodysplastic syndromes.
    Park DJ; Koeffler HP
    Semin Hematol; 1996 Jul; 33(3):256-73. PubMed ID: 8819235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.